Spero Therapeutics
SPRO
SPRO
60 hedge funds and large institutions have $24.6M invested in Spero Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
37% less capital invested
Capital invested by funds: $39.3M → $24.6M (-$14.7M)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Holders
60
Holding in Top 10
1
Calls
$382K
Puts
$226K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$600K | |
| 3 | +$325K | |
| 4 |
Renaissance Technologies
New York
|
+$222K |
| 5 |
Two Sigma Investments
New York
|
+$68.8K |
Top Sellers
| 1 | -$6.81M | |
| 2 | -$3.86M | |
| 3 | -$1.73M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$373K |